Abstract
Tributylstannic[3-(3,5 -dimethylphenylamido)propionate] is synthesized and characterized by elemental analysis, FT-IR, multinuclear NMR (1H, 13C and 119Sn) and mass spectrometry. The organic anion was found to act as monodentate O-bound ligand in solution. The compound was screened for the anti-HCV potency by the Gaussia luciferase Assay using infected Huh 7.5 cells (human hepatocellular cell) and is found active against HCV with logIC50 1.2nM in the cell-based assay. Cationic surfactant cetyl N,N,N-trimethylammoniumbromide (CTAB) was used to study the interactions of the organotin(IV) complex with positively charged micelles of the surfactant acting as a model cell membrane. The thermodynamics parameters of complex- CTAB interaction concluded that the complex is located in the palisade layer of CTAB micelles. The increase in absorbance of visible spectra of the compound confirmed its solubilization into micelles. The two carbonyl oxygen’s were found to be binding sites of the complex with CTAB.
Keywords: CTAB, drug delivery, HCV, organotin(IV) carboxylates, UV and fluorescence spectroscopies.
Infectious Disorders - Drug Targets
Title:Design, Synthesis, and Delivery Studies of Organotin(IV) based HCV Inhibitor
Volume: 15 Issue: 3
Author(s): Farooq A. Shah, Kaneez Fatima, Saqib Ali and Ishtiaq Qadri
Affiliation:
Keywords: CTAB, drug delivery, HCV, organotin(IV) carboxylates, UV and fluorescence spectroscopies.
Abstract: Tributylstannic[3-(3,5 -dimethylphenylamido)propionate] is synthesized and characterized by elemental analysis, FT-IR, multinuclear NMR (1H, 13C and 119Sn) and mass spectrometry. The organic anion was found to act as monodentate O-bound ligand in solution. The compound was screened for the anti-HCV potency by the Gaussia luciferase Assay using infected Huh 7.5 cells (human hepatocellular cell) and is found active against HCV with logIC50 1.2nM in the cell-based assay. Cationic surfactant cetyl N,N,N-trimethylammoniumbromide (CTAB) was used to study the interactions of the organotin(IV) complex with positively charged micelles of the surfactant acting as a model cell membrane. The thermodynamics parameters of complex- CTAB interaction concluded that the complex is located in the palisade layer of CTAB micelles. The increase in absorbance of visible spectra of the compound confirmed its solubilization into micelles. The two carbonyl oxygen’s were found to be binding sites of the complex with CTAB.
Export Options
About this article
Cite this article as:
Shah A. Farooq, Fatima Kaneez, Ali Saqib and Qadri Ishtiaq, Design, Synthesis, and Delivery Studies of Organotin(IV) based HCV Inhibitor, Infectious Disorders - Drug Targets 2015; 15 (3) . https://dx.doi.org/10.2174/1871526515666150903121956
DOI https://dx.doi.org/10.2174/1871526515666150903121956 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Regulation of Cell Migration and Invasion by Specific Modules of uPA: Mechanistic Insights and Specific Inhibitors
Current Drug Targets Aging as an Evolvability-Increasing Program Which can be Switched Off by Organism to Mobilize Additional Resources for Survival
Current Aging Science Frontotemporal Lobar Degeneration (FTLD): Review and Update for Clinical Neurologists
Current Alzheimer Research 20 Years of Lipid Nanoparticles (SLN & NLC): Present State of Development & Industrial Applications
Current Drug Discovery Technologies Polyunsaturated Fatty Acids in Emerging Psychosis
Current Pharmaceutical Design Origin and Expansion of Trinucleotide Repeats and Neurological Disorders
Current Genomics Adult and Embryonic Stem Cells in Cartilage Repair
Current Rheumatology Reviews Structure, Activities and Biomedical Applications of Human Butyrylcholinesterase
Protein & Peptide Letters Possible Involvement of TRP Channels in Cardiac Hypertrophy and Arrhythmia
Current Topics in Medicinal Chemistry Mesenchymal Stem Cells: Potential in Treatment of Neurodegenerative Diseases
Current Stem Cell Research & Therapy Sleep, Depression and Insomnia – A Vicious Circle?
Current Psychiatry Reviews Ceramide-Based Therapeutics for the Treatment of Cancer
Anti-Cancer Agents in Medicinal Chemistry Regulation of Dopamine Signaling in the Striatum by Phosphodiesterase Inhibitors: Novel Therapeutics to Treat Neurological and Psychiatric Disorders
Central Nervous System Agents in Medicinal Chemistry Material Couture for Wound Healing and Regeneration: an Overview
Current Pharmaceutical Design Rifaximin: An Antibiotic with Important Biologic Effects
Mini-Reviews in Medicinal Chemistry Molecular and Biochemical Features of the Mitochondrial Enzyme Ornithine Transcarbamylase: A Possible New Role as a Signaling Factor
Current Medicinal Chemistry Current Clinical Applications of Botulinum Toxin
Current Pharmaceutical Design Molecular Views and Measurements of Hemostatic Processes Using Atomic Force Microscopy
Current Protein & Peptide Science A Review on GABA/Glutamate Pathway for Therapeutic Intervention of ASD and ADHD
Current Medicinal Chemistry Update on Anti-TNF-Alpha Treatment in Rheumatic Diseases
Current Drug Therapy